Literature DB >> 25717221

Population-based cancer incidence analysis in Beijing, 2008-2012.

Lei Yang1, Yannan Yuan1, Tingting Sun1, Huichao Li1, Ning Wang1.   

Abstract

OBJECTIVE: To analyze the incidence of cancer during 2008-2012 in Beijing, China, and compare the cancer spectrum with that during 1998-1999.
METHODS: Data from the Beijing Cancer Registry (BCR), which covered 12 million residents and 16 administrative regions in Beijing, were checked and evaluated on basis of the criteria of data quality from the National Central Cancer Registry (NCCR) of China. Incidences were calculated stratified by cancer type, sex, areas (urban/rural), and age. The Chinese census population in 1982 and the world Segi's population were used for calculating the age-standardized incidences.
RESULTS: A total of 177,101 new cancer cases were diagnosed in Beijing between 2008 and 2012. The crude incidence rate (CR) of all cancers was 282.64/100,000 (290.71/100,000 in males and 274.45/100,000 in females). The age-standardized rates by Chinese standard population (ASR-China) and by world standard population (ASR-world) were 124.46/100,000 and 161.18/100,000, respectively. Female breast cancer was the most common cancer, followed by lung cancer, colorectal cancer, liver cancer, and stomach cancer, with the CR of 59.87/100,000, 59.21/100,000, 32.49/100,000, 19.81/100,000 and 17.96/100,000, respectively. In urban areas, female breast cancer (68.50/100,000) was still the most common cancer, followed by lung cancer (61.23/100,000), colorectal cancer (37.23/100,000), prostate cancer (20.49/100,000) and stomach cancer (20.07/100,000). In rural areas, lung cancer (55.94/100,000) was the most common cancer, followed by female breast cancer (45.87/100,000), colorectal cancer (24.77/100,000), liver cancer (20.68/100,000) and stomach cancer (14.52/100,000). Great changes of the cancer spectrum were found from the period of 1998-1999 to the period of 2011-2012 in Beijing.
CONCLUSIONS: The cancer burden in Beijing was heavier than the national average level. Cancer prevention and control strategies, especially for lung, colorectal, prostate and female thyroid cancers, should be enhanced.

Entities:  

Keywords:  Beijing; Cancer registry; epidemiology; incidence

Year:  2015        PMID: 25717221      PMCID: PMC4329184          DOI: 10.3978/j.issn.1000-9604.2015.01.07

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  7 in total

1.  The role of early-life socioeconomic status in breast cancer incidence and mortality: unraveling life course mechanisms.

Authors:  Tetyana Pudrovska; Benedicta Anikputa
Journal:  J Aging Health       Date:  2011-09-28

2.  [Relationship between female breast cancer incidence and the socioeconomic status in Beijing].

Authors:  Lei Yang; Tingting Sun; Yannan Yuan; Ning Wang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2014-09

3.  Estimation of cancer incidence and mortality attributable to smoking in China.

Authors:  Jian-Bing Wang; Yong Jiang; Wen-Qiang Wei; Gong-Huan Yang; You-Lin Qiao; Paolo Boffetta
Journal:  Cancer Causes Control       Date:  2010-03-10       Impact factor: 2.506

Review 4.  Infection and cancer: global distribution and burden of diseases.

Authors:  Jin-Kyoung Oh; Elisabete Weiderpass
Journal:  Ann Glob Health       Date:  2014 Sep-Oct       Impact factor: 2.462

5.  Smoking in China: findings of the 1996 National Prevalence Survey.

Authors:  G Yang; L Fan; J Tan; G Qi; Y Zhang; J M Samet; C E Taylor; K Becker; J Xu
Journal:  JAMA       Date:  1999-10-06       Impact factor: 56.272

6.  Annual report on status of cancer in China, 2010.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Hongmei Zeng; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

7.  Time trends of cancer incidence in urban beijing, 1998-2007.

Authors:  Ning Wang; Wei-Xing Zhu; Xiu-Mei Xing; Lei Yang; Ping-Ping Li; Wei-Cheng You
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

  7 in total
  11 in total

1.  The Incidence of Lymphoma in Beijing: Comparing Results from MIS-CASS (2019) and Beijing Cancer Registry (2017).

Authors:  Hongrui Tian; Weiping Liu; Yuqin Song; Lan Mi; Zhen Liu; Mengfei Liu; Chuanhai Guo; Fangfang Liu; Ying Liu; Yaqi Pan; Jun Zhu; Zhonghu He; Yang Ke
Journal:  China CDC Wkly       Date:  2021-12-24

2.  Expenditure of hospital care on cancer in China, from 2011 to 2015.

Authors:  Yue Cai; Ming Xue; Wanqing Chen; Maogui Hu; Zhiwen Miao; Lan Lan; Rongshou Zheng; Qun Meng
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

3.  Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.

Authors:  Xiaoli Zhu; Qianming Bai; Yongming Lu; Yiqiong Lu; Linlin Zhu; Xiaoyan Zhou; Lijing Wu
Journal:  Int J Oncol       Date:  2016-04-12       Impact factor: 5.650

Review 4.  A Systematic Review of Randomized Controlled Trials on Oral Chinese Herbal Medicine for Prostate Cancer.

Authors:  Huijuan Cao; Yujie Mu; Xun Li; Yuyi Wang; Shiuan Chen; Jian-Ping Liu
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

5.  Comparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists.

Authors:  Lixin Jiang; Zengwu Yao; Yifei Zhang; Jinchen Hu; Dawei Zhao; Huiyuan Zhai; Xixun Wang; Zhenbin Zhang; Dong Wang
Journal:  Chin J Cancer Res       Date:  2016-10       Impact factor: 5.087

6.  Incidence of Cancer in Shenzhen, Guangdong Province during 2001-2015: A Retrospective Population-Based Study.

Authors:  Zhongyu Xu; Haibin Zhou; Lin Lei; Hongyu Li; Weiye Yu; Zhen Fu; Nanjin Wu; Ji Peng; Ping Yin
Journal:  Int J Environ Res Public Health       Date:  2017-09-27       Impact factor: 3.390

7.  Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China.

Authors:  Chen Chen; Zhongqiu Xin
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  Characteristics, survival, and risk factors of Chinese young lung cancer patients: the experience from two institutions.

Authors:  Jianjie Li; Fan Yang; Xiao Li; Min Zhang; Ruozi Fu; Xiaodan Yin; Jun Wang
Journal:  Oncotarget       Date:  2017-07-12

9.  The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study.

Authors:  Tingting Zuo; Hongmei Zeng; Huichao Li; Shuo Liu; Lei Yang; Changfa Xia; Rongshou Zheng; Fei Ma; Lifang Liu; Ning Wang; Lixue Xuan; Wanqing Chen
Journal:  Chin J Cancer       Date:  2017-10-25

10.  Update analysis on the association between Methionine synthase rs1805087 A/G variant and risk of prostate cancer.

Authors:  Wei Zhang; Ze Zhang; Hao Wu; Kai Xu; Wei Yuan; Yuan-Yuan Mi; Li Shi; Li Zuo; Yun-Feng Shi
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.